The efficacy of rituximab in patients with chronic immune thrombocytopenic purpura. A single-centre experience

被引：0
|
作者：
Davis, Sarah [1 ]
Gamadia, Shireen [1 ]
机构：
[1] Milton Keynes Univ Hosp, Milton Keynes, Bucks, England
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2023年 / 201卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
BSH23-EP44
引用
收藏
页码：163 / 163
页数：1
相关论文
共 50 条
  • [1] The efficacy of rituximab in patients with chronic immune thrombocytopenic purpura. A single-centre experience
    Davis, Sarah
    Gamadia, Shireen
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 201 : 163 - 163
  • [2] Use of rituximab for immune thrombocytopenic purpura - a single centre experience
    Browning, J.
    Aggarwal, V.
    Murphy, M.
    Roberts, D.
    Pavord, S.
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 173 : 38 - 38
  • [3] Rituximab-associated immune thrombocytopenic purpura.
    Johnston, PB
    Inwards, DJ
    BLOOD, 1999, 94 (10) : 263B - 263B
  • [4] Mabthera (rituximab) in the treatment of 92 patients with refractory immune thrombocytopenic purpura.
    Cabrera, JR
    Penalver, FJ
    Almagro, M
    Alvarez-Larran, A
    Rodriguez, L
    BLOOD, 2004, 104 (11) : 571A - 571A
  • [5] Rituximab in chronic relapsing acquired thrombotic thrombocytopenic purpura.
    Giuffrida, G
    Figuera, A
    Cingari, R
    Maccarone, S
    Di Francesco, E
    Giustolisi, R
    BLOOD, 2005, 106 (11) : 79B - 79B
  • [6] Rituximab Efficacy in the Treatment of Children with Chronic Immune Thrombocytopenic Purpura
    Ansari, Sh
    Rostami, T.
    Yousefian, S.
    Kiumarsi, A.
    Miri-Aliabad, G.
    Ramim, T.
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2014, 31 (06) : 555 - 562
  • [7] Rituximab for refractory immune thrombocytopenic purpura:: A single center experience
    Arguinano, J.
    Burguete, Y.
    Ardaiz, M. A.
    Mateos, M. C.
    Montoya, M. C.
    Paloma, M. J.
    Redondo, A. M.
    Ezpeleta, I.
    Labaca, M. A.
    Oyarzabal, F. J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 423 - 424
  • [8] Efficacy of mycphenolate mofetil as single agent therapy for refractory immune thrombocytopenic purpura.
    Provan, A
    Jones, A
    Newland, AC
    Bussel, JB
    BLOOD, 2003, 102 (11) : 86B - 87B
  • [9] Chronic immune thrombocytopenic purpura. Important prognostic indicators
    MartinezMurillo, C
    Zepeda, J
    Quintana, GS
    Payns, BE
    Vazquez, ME
    Ambriz, FR
    THROMBOSIS AND HAEMOSTASIS, 1997, : P1106 - P1106
  • [10] Still a challenging problem: Chronic immune thrombocytopenic purpura.
    Unuvar, A
    Devecioglu, O
    Anak, S
    Agaoglu, L
    Yalman, N
    Karakas, Z
    Gedikoglu, G
    BLOOD, 2001, 98 (11) : 65B - 65B
12345